Science Explorer Interactive view Map
Company · Cambridge · United States

Constellation Pharmaceuticals (United States)

Research works
114
▼ 27% vs 2013–17
Citations
7.1k
62.5 per fractional work
Top-10% rate
29.0%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Constellation Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.69× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.72× its world share, 0 worksImmunology and Micro…Chemistry: 0.30× its world share, 0 worksChemistryComputer Science: 0.63× its world share, 0 worksComputer ScienceEngineering: 0.14× its world share, 0 worksEngineeringPhysics and Astronomy: 0.24× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.23× its world share, 0 worksHealth ProfessionsMedicine: 1.80× its world share, 4 worksMedicineNursing: 3.32× its world share, 0 worksNursingSocial Sciences: 0.77× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.7×. Every wedge is a field page.

Who are the top researchers at Constellation Pharmaceuticals (United States)?

Ranked on the composite score, Richard Cummings, Patrick Trojer and Gozde Colak lead among researchers whose main affiliation is Constellation Pharmaceuticals (United States).

  1. 1 Richard Cummings United States · #217,473 worldwide 240 citations · 20 works
  2. 2 Patrick Trojer United States · #828,012 worldwide 51 citations · 19 works
  3. 3 Gozde Colak United States · #1,050,876 worldwide 11 citations · 17 works
All ranked researchers at Constellation Pharmaceuticals (United States)

Which keywords describe research at Constellation Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Transcriptional Regulation, Epigenetic Regulation, BET Bromodomains, PROTACs, Cancer, DNA Methylation, Epigenetic Reprogramming and Histone Modification.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Transcriptional Regulation24▲ 83×4 topics
  2. Epigenetic Regulation18▲ 71×4 topics
  3. BET Bromodomains13▲ 581×1 topic
  4. Cancer13▲ 8.4×14 topics
  5. PROTACs13▲ 581×1 topic
  6. DNA Methylation13▲ 100×2 topics
  7. Epigenetic Reprogramming13▲ 146×1 topic
  8. Histone Modification13▲ 176×1 topic
  9. Cancer Therapy13▲ 17×5 topics
  10. Proteasome Inhibitors11▲ 132×2 topics
  11. Arginine Methylation10▲ 256×1 topic
  12. Protein Arginine Methyltransferases10▲ 256×1 topic
  13. Staging System8▲ 113×2 topics
  14. Gene Expression8▲ 12×3 topics
  15. Diagnosis Criteria8▲ 226×1 topic
  16. International Myeloma Working Group8▲ 226×1 topic
  17. HDAC Inhibitors8▲ 340×1 topic
  18. Histone Deacetylases8▲ 340×1 topic
  19. Tumor Microenvironment4▲ 9.0×6 topics
  20. Epigenetics3▲ 48×2 topics
  21. Cancer Progression3▲ 11×2 topics
  22. Gene Expression Regulation3▲ 21×2 topics
  23. Proteasome3▲ 61×1 topic
  24. Ubiquitin3▲ 61×1 topic
  25. RNA methylation3▲ 29×1 topic
  26. m6A-seq3▲ 29×1 topic
  27. Gene Regulation3▲ 15×2 topics
  28. Transcription Factors3▲ 16×2 topics
  29. Chromatin2▲ 23×1 topic
  30. Targeted Therapy2▲ 9.7×4 topics
  31. Transcription2▲ 52×1 topic
  32. PET Imaging2▲ 9.4×3 topics
  33. JAK2 Mutation2▲ 94×1 topic
  34. Myelofibrosis2▲ 94×1 topic
  35. Cancer Genomics2▲ 34×1 topic
  36. Mutational Signatures2▲ 34×1 topic
  37. Fibroblast Activation Protein2▲ 30×1 topic
  38. Immunosuppression2▲ 14×2 topics
  39. N-terminal Acetylation2▲ 30×1 topic
  40. Resistance2▲ 14×2 topics

Which research topics does Constellation Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Politics and Society in Latin America, Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Chronic Myeloid Leukemia Treatments.

  1. 1 Politics and Society in Latin America Political Science and International Relations 1 works
  2. 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  3. 3 Multiple Myeloma Research and Treatments Hematology 1 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 Cultural Insights and Digital Impacts Computer Networks and Communications 0 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 0 works
  8. 8 Genomics and Chromatin Dynamics Molecular Biology 0 works
  9. 9 Genomics and Phylogenetic Studies Molecular Biology 0 works
  10. 10 Geriatric Care and Nursing Homes General Health Professions 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.3%not open55.7%

World: 28% of research is openly available.

with international co-authors25.1%domestic only74.9%

World: 19% is written across borders.

How has Constellation Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 27% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.